NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
15 hedge funds and large institutions have $812K invested in NeuroMetrix, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
6% less funds holding
Funds holding: 16 → 15 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
49% less capital invested
Capital invested by funds: $1.6M → $812K (-$784K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$18.5K |
| 2 |
Renaissance Technologies
New York
|
+$15.4K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$11.7K |
| 4 |
BlackRock
New York
|
+$4.53K |
| 5 |
Morgan Stanley
New York
|
+$4.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$97K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$28K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$16.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$199 |
NURO Hedge Fund Activity: Q4 2022 in Review
15 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q4 2022, worth a combined $812K — down 49% from $1.6M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NURO and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 6 added.
The largest buyer was Millennium Management, adding an estimated $18.5K. The largest seller was Citadel Advisors, exiting entirely with an estimated $97K sold.
- 15 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q4 2022, down from 16 in Q3 2022.
- Funds reported $812K of NeuroMetrix, Inc. Common Stock stock for Q4 2022, down 49% quarter-over-quarter.
- 2 funds opened new NeuroMetrix, Inc. Common Stock positions in Q4 2022 and 3 closed out, a net change of -1 holder.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q4 2022 was Millennium Management, an estimated $18.5K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q4 2022 was Citadel Advisors, an estimated $97K sold.
Based on aggregated 13F filings for Q4 2022.